Switch to:
More From Other Websites
When Profit Makers Can Be Active Profit Takers Mar 16 2017
Coverage initiated on Exelixis by Oppenheimer Mar 16 2017
ETFs with exposure to Exelixis, Inc. : March 6, 2017 Mar 06 2017
Exelixis' Cabozantinib Granted Orphan Drug Designation for the Treatment of Hepatocellular Carcinoma Mar 06 2017
EXELIXIS, INC. Financials Mar 03 2017
Blog Coverage Intercept Pharmaceuticals Received NICE Approval for Ocaliva for Use in England, Wales... Mar 03 2017
Exelixis, Inc. :EXEL-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017 Mar 02 2017
Zacks Industry Outlook Highlights: GlaxoSmithKline, Celgene and Exelixis Mar 02 2017
Exelixis Announces Webcasts of Investor Conference Presentations in March Mar 01 2017
M&As, Pipeline Catalysts to Drive Pharma Sector Mar 01 2017
Exelixis, Inc. :EXEL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 1, 2017 Mar 01 2017
Biotech Stock Roundup: Kite Soars on CAR-T Data, EXEL in Immuno-Oncology Deals Mar 01 2017
Exelixis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Feb 28 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK